Barclays PLC Buys 3,118 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Barclays PLC raised its stake in Utah Medical Products, Inc. (NASDAQ:UTMD) by 214.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,574 shares of the medical instruments supplier’s stock after acquiring an additional 3,118 shares during the period. Barclays PLC owned about 0.13% of Utah Medical Products worth $306,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Copeland Capital Management LLC bought a new stake in shares of Utah Medical Products in the 3rd quarter worth about $53,000. BNP Paribas Financial Markets grew its stake in Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 566 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in shares of Utah Medical Products during the second quarter worth approximately $83,000. Victory Capital Management Inc. raised its stake in shares of Utah Medical Products by 124.4% in the second quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock valued at $179,000 after acquiring an additional 1,482 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new position in shares of Utah Medical Products in the 3rd quarter worth approximately $231,000. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Stock Performance

UTMD opened at $61.35 on Friday. Utah Medical Products, Inc. has a 1-year low of $60.39 and a 1-year high of $85.76. The stock has a market capitalization of $208.10 million, a PE ratio of 14.37 and a beta of 0.08. The firm has a 50-day moving average price of $64.06 and a two-hundred day moving average price of $66.17.

Utah Medical Products Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Monday, December 16th were given a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 1.99%. The ex-dividend date was Monday, December 16th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s payout ratio is 28.57%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.